World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 23

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10184)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

1067

HTML

6885

Figures (1-2)

502

Tables (1-2)

463

Sum=8917

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

195

Download

693

Sum=888

Jun 21, 2024 (publication date) through Apr 28, 2026

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Rochoń J, Kalinowski P, Szymanek-Majchrzak K, Grąt M. Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(23): 2964-2980 [PMID: 38946874 DOI: 10.3748/wjg.v30.i23.2964]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i23/2964.htm

Number	Citing Articles
1	Andrea M. Tou, Jennifer Panganiban. Metabolic Bariatric Surgery as a Disease-Modifying Therapy for Pediatric Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) Within an Evolving Therapeutic Framework. The Journal of Pediatrics 2026; 293: 115011 doi: 10.1016/j.jpeds.2026.115011
2	Boris Dinkov, Diana Pendicheva-Duhlenska. The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, and MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review. Biomedicines 2026; 14(4): 806 doi: 10.3390/biomedicines14040806
3	Evangelia E. Tsakiridis, Gregory R. Steinberg. Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression. Diabetes, Obesity and Metabolism 2026; 28(S2): 31 doi: 10.1111/dom.70624
4	Wissam Ghusn, Mira Sridharan, Rachel Fromer, Muhammet Ozdemir, Madeleine G. Haff, Eric J. Vargas. Endoscopic Bariatric Therapies for Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Insights and Metabolic Implications. Biomedicines 2025; 13(10): 2437 doi: 10.3390/biomedicines13102437
5	Hui Sun, Le Yang, Ye Sun, Xinya Zhang, Xin Sun, Xueping Zhao, Hui Sun, Qimeng Zhang, Guangli Yan, Xijun Wang. Dysregulated bile acid metabolism as a novel player in gout progression: emerging therapeutic strategies. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1676017
6	Chia‐Chih Kuo, Min‐Hsiang Chuang, Chun‐Hsien Li, Ya‐Wen Tsai, Po‐Yu Huang, Hsing‐Tao Kuo, Chih‐Cheng Lai. Glucagon‐Like Peptide‐1 Receptor Agonists and Liver Outcomes in Patients With MASLD and Type 2 Diabetes. Alimentary Pharmacology & Therapeutics 2025; 61(7): 1163 doi: 10.1111/apt.18502
7	Houda Zoubiri, Wassila Saiah, Amel Otmane, Hamza Saidi, Mohamed Makrelouf, Samir Ait Abderrhmane, Ali El Mahdi Haddam, Elhadj-Ahmed Koceir. Plasma GLP-1 (Glucagon-like Peptide-1) Depletion Is Correlated with Dysregulation of Adipocytokine in Type 2 Diabetic Patients With or Without Metabolic-Associated Fatty Liver Disease (MAFLD): A Cross-Sectional Study Related to Gender-Sex Disparities. International Journal of Molecular Sciences 2026; 27(3): 1218 doi: 10.3390/ijms27031218
8	Yu.M. Stepanov, O.V. Zinych, I.A. Klenina, K.O. Shyshkan-Shyshova, N.M. Kushnarоva. Efficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus. GASTROENTEROLOGY 2025; 59(2): 114 doi: 10.22141/2308-2097.59.2.2025.675
9	Diego F. Wyszynski. Non-alcoholic Fatty Liver Disease in Pregnancy: Clinical Implications, Adverse Outcomes, and Therapeutic Considerations. Journal of Clinical and Experimental Hepatology 2026; 16(2): 103431 doi: 10.1016/j.jceh.2025.103431
10	Merve Guney-Coskun, Metin Basaranoglu. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World Journal of Gastroenterology 2024; 30(43): 4682-4688 doi: 10.3748/wjg.v30.i43.4682 Abstract(549) \| Core Tip(528) \| Full Article(HTML)(7522) \| Full Article with Cover (PDF)-1577K(183) \| Audio-1593K(14) \| Peer-Review Report-245K(117) \| Answering Reviewers-147K(98) \| Full Article (PDF)-1223K(304) \| Full Article (XML)-96K(102) \| Times Cited (15) \| Total Visits (10971) \| Open
11	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(799) \| Core Tip(817) \| Full Article(HTML)(1715) \| Full Article with Cover (PDF)-639K(202) \| Audio-785K(15) \| Peer-Review Report-230K(116) \| Answering Reviewers-209K(125) \| Full Article (PDF)-410K(151) \| Full Article (XML)-117K(122) \| Times Cited (0) \| Total Visits (6104) \| Open
12	Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Role of intestinal glucagon-like peptide-1 in hypoglycemia response impairment in type 1 diabetes. World Journal of Diabetes 2024; 15(11): 2237-2241 doi: 10.4239/wjd.v15.i11.2237 Abstract(507) \| Core Tip(543) \| Full Article(HTML)(3965) \| Full Article with Cover (PDF)-801K(132) \| Audio-213K(12) \| Peer-Review Report-237K(112) \| Answering Reviewers-97K(110) \| Full Article (PDF)-365K(132) \| Full Article (XML)-41K(104) \| Times Cited (0) \| Total Visits (6879) \| Open
13	Ioannis Ilias, Lina Zabuliene, Manfredi Rizzo. GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks. Frontiers in Clinical Diabetes and Healthcare 2025; 5 doi: 10.3389/fcdhc.2024.1530811
14	Bisma Fatima Hammad, Nimrah Zafar, Muneeb Ullah, Syeda Jazilah Faisal, Fizzah Iftikhar, Haadia Waheed, Muhammad Waleed Muzaffar, Khadija Ahmed, Faz Ashraf, Komal Zahid, Maimoona Akhtar, Mohammed Mahmmoud Fadelallah Eljack. Exploring the multifaceted roles of GLP-1 receptor agonists; a comprehensive review. Frontiers in Clinical Diabetes and Healthcare 2025; 6 doi: 10.3389/fcdhc.2025.1590530
15	Yining Xu, Daniel J Drucker, Giovanni Traverso, Ana Beloqui. Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies. Endocrine Reviews 2026; 47(1): 1 doi: 10.1210/endrev/bnaf027
16	Yonglu Li, Xin Gao, Lihan Jiang, Hongdi Song, Chen Yang, Cong Wu, Yapeng Li, Shihai Yan, Ping Li, Qing Gu. Beyond the oral niche: Lacticaseibacillus paracasei LPC-37 unlocks oral-gastric-intestinal crosstalk for butyric acid-dependent oral inflammation alleviation. Food & Function 2025; 16(20): 8095 doi: 10.1039/D5FO02279G
17	Mykhailo Buchynskyi, Iryna Kamyshna, Iryna Halabitska, Pavlo Petakh, Oksana Kunduzova, Valentyn Oksenych, Oleksandr Kamyshnyi. Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1577724
18	Li Lin, Shaowei Xiang, Yuan Chen, Yan Liu, Dingwen Shen, Xiaoping Yu, Zhe Wu, Yanling Sun, Kequan Chen, Jia Luo, Guilai Wei, Zhiguo Wang, Zhifeng Ning. Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review). Experimental and Therapeutic Medicine 2024; 28(5) doi: 10.3892/etm.2024.12716
19	Yanqiu Li, Bingbing Zhu, Ke Shi, Yu Lu, Xuanwei Zeng, Yongqi Li, Qun Zhang, Ying Feng, Xianbo Wang. Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1515400
20	Chuwen Lin, Weijiong Chen, Shuang Liu, Baige Cao, Yan Ge, Yan Li, Yuanyuan Liu, Tiantian Guo, Jinfang Xu, Congrong Wang. Hongkou Advanced Research on Metabolism and Obesity iNtervention studY (HARMONY): a protocol for a longitudinal cohort study. BMJ Open 2026; 16(4): e115236 doi: 10.1136/bmjopen-2025-115236
21	Andrea M. Tou, Jennifer Panganiban. Glucagon‐like peptide‐1 receptor agonists in pediatric metabolic dysfunction‐associated steatotic liver disease. Journal of Pediatric Gastroenterology and Nutrition 2026; 82(1): 146 doi: 10.1002/jpn3.70242
22	Mona Mohamed Ibrahim Abdalla. Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities. World Journal of Gastroenterology 2025; 31(29): 109090 doi: 10.3748/wjg.v31.i29.109090 Abstract(188) \| Core Tip(184) \| Full Article(HTML)(3349) \| Full Article with Cover (PDF)-6241K(131) \| Audio-364K(9) \| Peer-Review Report-260K(44) \| Answering Reviewers-194K(48) \| Full Article (PDF)-4795K(148) \| Full Article (XML)-364K(47) \| Times Cited (11) \| Total Visits (5968) \| Open
23	Junling Li, Qianru Gao, Hongtao Liu, Songlin Liu, Yanchun Wang, Xiongjie Sun, Junping Zheng, Huabing Yang, Baifei Hu. Integrating 16S rDNA sequencing analysis and targeted metabolomics to explore the mechanism of Xiexin Tang in treating atherosclerosis mice induced by high-fat diet. Journal of Pharmaceutical and Biomedical Analysis 2025; 259: 116760 doi: 10.1016/j.jpba.2025.116760
24	Zixuan Hu, Dianzhe Tian, Zuyi Yang, Junwei Zhang, Lei Zhang, Yiyao Xu, Xin Lu. The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1754721
25	Xue-Dong An, Xin-Qin Li, He Zhang, Qian-You Jia, Gui-Gui Yang, Yue-Hong Zhang. Comparison of three types of drugs for cardiovascular and renal benefits in type 2 diabetes mellitus. World Journal of Diabetes 2025; 16(11): 111280 doi: 10.4239/wjd.v16.i11.111280 Abstract(66) \| Core Tip(61) \| Full Article(HTML)(396) \| Full Article with Cover (PDF)-7610K(27) \| Audio-1045K(8) \| Peer-Review Report-277K(22) \| Answering Reviewers-142K(21) \| Supplementary Material-370K(27) \| Full Article (PDF)-7411K(100) \| Full Article (XML)-175K(23) \| Times Cited (1) \| Total Visits (1828) \| Open